Recital 10, Regulation (EU) 2024/2781

In forcesince 31 Oct 2024

It is therefore likely that no decision on the renewal of the approvals of those active substances can be taken before the expiry of their respective approval periods on 31 December 2024, and the reasons for the delays in the renewal procedures are beyond the control of the respective applicants. Therefore, the approval periods of those active substances should be extended in order to enable the completion of the assessments required and to finalise the respective procedures on renewal of approval.